Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events (Q37872648)

24 August 2017

1 reference

title

Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events (English)

1 reference

24 August 2017

Robert Guthrie

1

1 reference

24 August 2017

language of work or name

English

0 references

publication date

3 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

28

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

473-482

1 reference

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Definition and Evaluation of Transient Ischemic Attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Timing of TIAs preceding stroke: time window for prevention is very short

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

National Stroke Association guidelines for the management of transient ischemic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Short-term prognosis after emergency department diagnosis of TIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Very early risk of stroke after a first transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Hospital-level variation in mortality and rehospitalization for medicare beneficiaries with acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Dipyridamole bioavailability in subjects with reduced gastric acidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Rapid development of tolerance to dipyridamole-associated headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Dose titration to reduce dipyridamole-related headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

Thrombotic thrombocytopenic purpura associated with clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0026-0

10.1007/S12325-011-0026-0

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference